Linagliptin as add‐on to empagliflozin and metformin in patients with type 2 diabetes: Two 24‐week randomized, double‐blind, double‐dummy, parallel‐group trials
Tinahones, Francisco J., Gallwitz, Baptist, Nordaby, Matias, Götz, Sophia, Maldonado‐Lutomirsky, Mario, Woerle, Hans J., Broedl, Uli C.
Published in Diabetes, obesity & metabolism (01.02.2017)
Published in Diabetes, obesity & metabolism (01.02.2017)
Get full text
Journal Article
LINAGLIPTIN (LINA) AS ADD-ON TO EMPAGLIFLOZIN (EMPA) AND METFORMIN (MET) IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM): TWO 24-WEEK RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL-GROUP TRIALS - STUDY DESIGN
Tinahones, Francisco, Gallwitz, Baptist, Nordaby, Matias, Götz, Sophia, Maldonado-Lutomirsky, Mario
Published in Endocrine practice (01.05.2016)
Get full text
Published in Endocrine practice (01.05.2016)
Journal Article
Abstract #286: Linagliptin (LINA) as Add-On to Empagliflozin (EMPA) and Metformin (MET) in Patients with Type 2 Diabetes Mellitus (T2DM): Two 24-Week Randomized, Doubleblind, Double-Dummy, Parallel-Group Trials – Study Design
Tinahones, Francisco, Gallwitz, Baptist, Nordaby, Matias, Götz None, Sophia, Maldonado-Lutomirsky, Mario
Published in Endocrine practice (01.05.2016)
Published in Endocrine practice (01.05.2016)
Get full text
Journal Article
PHARMACOKINETICS OF SINGLE AND MULTIPLE RISING DOSES OF BI 425809, A NEW GLYT1 INHIBITOR, IN YOUNG AND ELDERLY HEALTHY VOLUNTEERS
Moschetti, Viktoria, Schlecker, Christina, Schultz, Armin, Wind, Sven, Goetz, Sophia, Liesenfeld, Karl-Heinz, Schmitt, Holger, Mao, Yan, Ren, Bailuo, Wunderlich, Glen, Yum, Sun-Young A., Desch, Michael
Published in Alzheimer's & dementia (01.07.2016)
Published in Alzheimer's & dementia (01.07.2016)
Get full text
Journal Article